MedCity News

JULY 9, 2023

Neko Health recently raised €60 million (about $65.8 million) in Series A financing. The Stockholm-based startup’s medical scanning technology aims to conveniently and affordably collect extensive health data to aid doctors in catching diseases early. The company’s scan takes about 10 minutes and costs €250 (about $275).

Doctors 89

Doctors Medical 89

PharmaTech

JULY 9, 2023

There has been a Growing concern among regulators driving a need for awareness for manufacturers to understand the risk associated with nitrosamines in pharmaceutical and biopharmaceutical products. In this session of Changing the Conversation with SGS Live, we tackled a variety of aspects of this important issue from the risk associated with nitrosamine contamination to discovery and mitigation of nitrosamine impurities.

Manufacturing 52

Manufacturing Pharmaceutical 52

MedCity News

JULY 9, 2023

A partial clinical trial hold has been lifted from cancer drug emavusertib and Curis has selected a dose to use in Phase 2 testing. The small molecule is being developed as a potential treatment for blood cancers.

FDA 86

FDA Biopharma Pharma 86

Veeva

JULY 9, 2023

The model of HCP engagement has been evolving to meet some of the key challenges the industry is facing. The biggest challenge is to identify the most effective way to optimise customer engagement through dynamic and personalised communications. Engagement of sales reps is always the number one challenge that comes up, while other challenges include segmentation targeting; performance tracking; insights and more.

Sales 52

Sales Healthcare Healthcare Distribution 52

Advertisement

Distribution

Pharmaceutical Technology

JULY 9, 2023

In this issue: Artificial intelligence tools for patients, EU funding for British biotech, analytics for continuous manufacturing, Apple’s play for the metaverse.

Patients 52

Patients Manufacturing 52

MedCity News

JULY 9, 2023

The Biden Administration is proposing that short-term health plans are limited to three months, or a maximum of four months if they’re extended. It comes after the Trump Administration allowed members to stay on the plans for 12 months and renew them for three years. The plans are often limited in coverage and leave consumers with high medical costs.

Insurance 99

Insurance Medical 99